The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801

INTRODUCTION: We report the long-term results of RTOG 9801, a randomized trial investigating the ability of amifostine, a radioprotector, to reduce chemoradiation-induced esophagitis. METHODS: Patients with stage II and IIIA/B non-small-cell lung cancer received induction paclitaxel 225 mg/m(2) intr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Richard, Lawrence Yaacov, Rebecca, Paulus, Corey, Langer, Maria, Werner-Wasik, Buyyounouski Mark, K, Ritsuko, Komaki, Mitchell, Machtay, Colum, Smith, Axelrod Rita, S, Todd, Wasserman, Bradley Jeffrey, D, Benjamin, Movsas
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3646966/
https://ncbi.nlm.nih.gov/pubmed/23477890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2013.02.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados